We analyzed the correlation between IHC-based molecular subtypes (luminal B/HER2-positive, HER2-positive/non-luminal and TN breast cancer), histological type (ductal invasive breast cancer and others), tumor grade, Ki67% value, tumor size, clinical lymph node status, cTNM stage, surgery, and clinical outcome. This evidence concerns the gene ERBB2 and breast cancer.